Esperion Therapeutics, Inc.

NasdaqGM:ESPR Stock Report

Market Cap: US$409.2m

Esperion Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:ESPR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 May 24SellUS$477Eric WarrenIndividual192US$2.48
20 Sep 23SellUS$924Eric WarrenIndividual742US$1.25
18 Aug 23SellUS$344Eric WarrenIndividual243US$1.41
19 Jul 23SellUS$168Eric WarrenIndividual106US$1.59
21 Jun 23SellUS$894Eric WarrenIndividual603US$1.48

Insider Trading Volume

Insider Buying: ESPR insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of ESPR?
Owner TypeNumber of SharesOwnership Percentage
Private Companies32,1730.017%
Individual Insiders1,197,2600.632%
VC/PE Firms13,708,7317.24%
General Public62,120,18332.8%
Institutions112,401,94659.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 100%.


Top Shareholders

Top 25 shareholders own 59.88% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.24%
OrbiMed Advisors LLC
13,708,731US$29.6m0%0.42%
5.25%
Bellevue Asset Management AG
9,944,064US$21.5m137%0.24%
4.82%
Wasatch Advisors LP
9,129,647US$19.7m2.68%0.07%
4.66%
The Vanguard Group, Inc.
8,826,546US$19.1m71.8%no data
4.22%
Great Point Partners, LLC
8,000,000US$17.3m0%3.25%
4.18%
Woodline Partners LP
7,922,229US$17.1m2,630%0.16%
3%
Millennium Management LLC
5,681,744US$12.3m64.7%0.01%
2.71%
D. E. Shaw & Co., L.P.
5,143,486US$11.1m324%0.02%
2.39%
Bank of America Corporation, Asset Management Arm
4,531,762US$9.8m2,860%no data
2.2%
Two Seas Capital LP
4,165,657US$9.0m-45.8%1.9%
2.1%
Two Sigma Investments, LP
3,975,560US$8.6m70.3%0.02%
2%
Meditor Group Ltd.
3,791,300US$8.2m0%3.83%
1.88%
Two Sigma Advisers, LP
3,569,700US$7.7m66.3%0.02%
1.78%
Goldman Sachs Group, Investment Banking and Securities Investments
3,364,266US$7.3m218%no data
1.77%
Citadel Advisors LLC
3,362,210US$7.3m627%0.01%
1.5%
BlackRock, Inc.
2,838,820US$6.1m34.4%no data
1.17%
Marshall Wace LLP
2,215,961US$4.8m384%0.01%
1.13%
Susquehanna International Group, LLP, Asset Management Arm
2,138,069US$4.6m41.9%0.01%
1.12%
Renaissance Technologies LLC
2,116,500US$4.6m49%0.01%
0.93%
Geode Capital Management, LLC
1,753,193US$3.8m57.6%no data
0.85%
Qube Research & Technologies Ltd
1,607,312US$3.5m269%0.01%
0.84%
Platinum Investment Management Limited
1,597,542US$3.5m-43.2%0.09%
0.79%
Morgan Stanley, Investment Banking and Brokerage Investments
1,505,616US$3.3m63.4%no data
0.74%
JP Morgan Asset Management
1,410,302US$3.0m-4.68%no data
0.6%
Parkman Healthcare Partners LLC
1,142,897US$2.5m-19.8%0.31%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.